Higher MDMX expression was associated with hypomethylating agent resistance and inferior survival in MDS patients, inferring it a potential therapeutic target

Yu-Hung Wang, Chien-Chin Lin, Kristian Gurashi, Bettina Wingelhofer, Fabio M R Amaral, Chi-Yuan Yao, Hsin Ting Hsieh, Ming Chih Liu, Hsin-An Hou, Wen-Chien Chou, Kiran Batta, Daniel H Wiseman, Hwei-Fang Tien

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)2507-2511
Number of pages5
Issue number12
Publication statusPublished - Dec 2023


  • Humans
  • Myelodysplastic Syndromes/drug therapy
  • Prognosis
  • Azacitidine/pharmacology

Cite this